clinical trials tirzepatide FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes A new Breakthrough T1D-funded clinical
Description
Obesity and Type 2 Diabetes has an increasing prevalence worldwide, presenting a major health challenge
Additionally, we highlight the gaps for further studies in clinical applications of GLP-1 RAs in aging-related diseases
The study protocol and redacted clinical study report will be available according to Novo Nordisk data sharing commitments
Canada, Brazil, and Turkey follow in the same wave
Clinical trials and pooled analyses have shown that the combination has a safety profile similar to each component alone, with a low incidence of hypoglycemia (unless combined with insulin or sulfonylureas)
